Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (36956)	12/30/1998 8:56:00 PM
From: bob	Respond to of 119973

JEB, More news that never hit the wires. Company has over 100 patents pending, so they decided not to do PR's on them when granted; To: Steve Research (113 ) From: bob Monday, Dec 28 1998 3:06PM ET Reply # of 117 Steve, US PATENT ISSUED TO CLPA! Patent #5852035 has been issued. United States Patent 5,852,035 Pamukcu , et al. December 22, 1998 -------------------------------------------------------------------------------- Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines Abstract A method for inhibiting neoplastic cells and related conditions by exposing them to substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo›3,4-B!quinolin-4-amines. -------------------------------------------------------------------------------- Inventors: Pamukcu; Rifat (Spring House, PA); Piazza; Gary A. (Doylestown, PA) Assignee: Cell Pathways, Inc. (Horsham, PA) Appl. No.: 989357 Filed: December 12, 1997 Go to the US Patent Office website and search under patent #'s to read the entire patent. Very extensive. Bob